Jeonju, South Korea

Kitae Park

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kitae Park. Retrieved from https://idiyas.com/inventor/kitae-park-8bm4elop

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Kitae Park from Jeonju, South Korea**

Introduction

Kitae Park is a prominent inventor based in Jeonju, South Korea, known for his significant contributions to the field of drug delivery systems. With a total of two patents to his name, his work focuses on innovative compositions that enhance the efficacy and stability of drug and nucleic acid delivery methods.

Latest Patents

Kitae Park's latest patents include two groundbreaking innovations:

1. **Drug delivery system using hyaluronic acid-peptide conjugate micelle**

This patent presents a novel drug delivery composition comprising a hyaluronic acid-peptide conjugate micelle and outlines a production method for this system. The unique feature of this invention is its ability to encapsulate drugs using a mixed solvent of aqueous and organic solutions. This biocompatible and biodegradable micelle can carry various water-insoluble active components, ensuring safe application for human use. Additionally, the therapeutic effect from the included peptide can enhance the overall efficacy of the drug, providing an extended duration of medicinal impact through sustained release formulations.

2. **Composition for nucleic acid delivery using metal nanoparticles and preparing method thereof**

This invention focuses on a composition designed for the delivery of nucleic acids, showcasing outstanding stability in bodily environments and enhanced intracellular delivery efficiency. The method described allows for targeted delivery, making it a vital tool in modern therapeutic strategies. This composition addresses the critical need for effective nucleic acid delivery, which is essential in various biomedical applications.

Career Highlights

Kitae Park is affiliated with the Postech Academy-Industry Foundation, where he engages in innovative research and development. His work emphasizes solving complex challenges in drug delivery systems and creating efficient methodologies for therapeutic applications.

Collaborations

Throughout his career, Kitae Park has collaborated with esteemed colleagues, including Sei Kwang Hahn and Ki Su Kim. These partnerships have fostered a supportive environment for innovation, enabling the development of advanced technologies in the biomedical field.

Conclusion

Kitae Park's contributions to the domain of drug delivery systems and nucleic acid delivery compositions position him as a noteworthy inventor in his field. His patents not only reflect his expertise but also hold the potential to significantly enhance therapeutic applications in medicine. Through his work, Kitae Park continues to make strides in the pursuit of innovative solutions for effective drug delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…